TP53 and breast carcinoma: The pro-apoptotic activity of Pfn1 has been causally linked to its ability to increase p53 and IκBα (negative regulator of NFκB) levels in breast cancer cell lines (Yao et al., 2013; Zaidi and Manna, 2016; Zaidi et al., 2016).